HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patricia L Mitchell Selected Research

10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acid

1/2021Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice.
1/2017Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
6/2014Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patricia L Mitchell Research Topics

Disease

8Insulin Resistance
01/2022 - 07/2011
8Atherosclerosis
10/2021 - 01/2004
7Non-alcoholic Fatty Liver Disease
05/2022 - 01/2019
6Inflammation (Inflammations)
11/2021 - 06/2014
5Obesity
10/2021 - 07/2015
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 07/2015
4Body Weight (Weight, Body)
11/2021 - 07/2011
4Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 01/2012
3Dyslipidemias (Dyslipidemia)
01/2019 - 07/2015
2Type 2 Diabetes Mellitus (MODY)
11/2021 - 06/2014
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2021 - 01/2018
2Aortic Valve Stenosis (Aortic Stenosis)
07/2021 - 09/2020
1Chronic Disease (Chronic Diseases)
11/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Disease Progression
01/2020
1Endotoxemia
01/2020
1Morbid Obesity
01/2019
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2019
1Abdominal Obesity
10/2018
1Glucose Intolerance
07/2015
1Overweight
07/2011
1Warts (Wart)
12/2002
1Cicatrix (Scar)
12/2002
1Pain (Aches)
12/2002

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2015
6Insulin (Novolin)FDA Link
01/2022 - 10/2008
6Conjugated Linoleic AcidsIBA
01/2012 - 01/2004
5Biomarkers (Surrogate Marker)IBA
05/2022 - 07/2011
5LipidsIBA
11/2021 - 07/2011
5Lipoproteins (Lipoprotein)IBA
11/2021 - 06/2005
5CholesterolIBA
01/2020 - 10/2008
4Apolipoproteins E (ApoE)IBA
11/2021 - 08/2008
3AdiponectinIBA
01/2022 - 10/2008
3Proteins (Proteins, Gene)FDA Link
11/2021 - 07/2015
3Lipoprotein(a)IBA
07/2021 - 09/2020
310,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA
01/2021 - 06/2014
2Cholecalciferol (Vitamin D3)FDA Link
11/2021 - 10/2021
2Peptides (Polypeptides)IBA
10/2021 - 07/2015
2Biological ProductsIBA
07/2021 - 06/2005
2oxidized low density lipoproteinIBA
04/2021 - 07/2011
2Sucrose (Saccharose)IBA
01/2021 - 01/2020
2Docosahexaenoic AcidsIBA
01/2021 - 01/2017
2HDL LipoproteinsIBA
10/2018 - 01/2018
2HDL CholesterolIBA
10/2018 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 06/2014
2Fatty Acids (Saturated Fatty Acids)IBA
06/2014 - 01/2012
1Tyrosine (L-Tyrosine)FDA Link
05/2022
1Blood Glucose (Blood Sugar)IBA
11/2021
1Calcium-Binding ProteinsIBA
11/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1RNA (Ribonucleic Acid)IBA
11/2021
1acetoacetic acid (acetoacetate)IBA
11/2021
1Pharmaceutical PreparationsIBA
11/2021
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2021
1ApolipoproteinsIBA
11/2021
1Vitamin DFDA LinkGeneric
10/2021
1Apoprotein(a) (Apolipoprotein (a))IBA
04/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2021
1Fish OilsIBA
01/2021
124-hydroxycholesterolIBA
01/2021
117- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1EnzymesIBA
01/2021
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021
1Insulysin (Insulin-Degrading Enzyme)IBA
01/2021
1Galectin 3 (LGALS3)IBA
01/2021
1SugarsIBA
01/2020
1Dietary Fats (Dietary Fat)IBA
01/2020
1Dietary Sucrose (Table Sugar)IBA
01/2020
1Persistent Organic PollutantsIBA
01/2020
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2019
1LeptinIBA
01/2019
1Triglycerides (Triacylglycerol)IBA
10/2018
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018
1TP-113IBA
01/2017
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1CytokinesIBA
07/2015
1Fish ProteinsIBA
07/2015
1Apolipoprotein B-100 (Apo B 100)IBA
07/2015
1ChemokinesIBA
07/2015
1SecretagoguesIBA
06/2014
1MyokinesIBA
06/2014
1LDL CholesterolIBA
07/2011
1C-Reactive ProteinIBA
07/2011
1oil red OIBA
06/2005
1Linoleic Acid (Linoleate)IBA
06/2005
1VLDL LipoproteinsIBA
01/2004
1Sodium Salicylate (Salicylate, Sodium)IBA
12/2002

Therapy/Procedure

2Bariatric Surgery
05/2022 - 01/2019
2Therapeutics
01/2018 - 06/2014
1Caloric Restriction
01/2019
1Biliopancreatic Diversion
01/2019
1Electrocoagulation (Electrocautery)
12/2002